Author Question: An interviewer is assigned to visit 123 eligible households. After the first approach to each ... (Read 103 times)

a0266361136

  • Hero Member
  • *****
  • Posts: 538
An interviewer is assigned to visit 123 eligible households. After the first approach to each household, 52 contacts have been made. At this stage, what is the interviewer's contact rate?
 a. 42.3
  b. 48.1
  c. 2.36 per hundred
  d. 52.0
  e. Cannot be determined from the information given.

Question 2

Which of the following is TRUE?
 a. The percentage of not-at-homes has been decreasing for a long time.
  b. Answering machines help interviewers schedule callback times.
  c. It is much easier to find a responsible adult at home than a specific respondent.
  d. One to two calls are often needed to reach three-fourths of the sample of households.
  e. To maintain consistency, callbacks should be made at the same time as the original call.



sierrahalpin

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

a

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library